CYTOR and metastatic malignant neoplasm in the lymph nodes: According to clinicopathological feature analysis (Table 1), higher CYTOR expression was observed more frequently in patients with larger tumor size (P = 0.011), advanced TNM stage (P= 0.024) and lymph node metastasis (P = 0.024).